Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

April 10, 2019 | Daily News

House Energy & Commerce oversight Chair Diana DeGette (D-CO) said Wednesday (April 10) she hopes to have ready by July or September bipartisan legislation that makes insulin affordable.

April 10, 2019 | Daily News

Senate Finance Chair Chuck Grassley (R-IA) said Wednesday (April 10) if senators cannot reach consensus on a package to lower prescription drug costs by June, such a package may not pass this year.

April 10, 2019 | Daily News

FDA is requiring changes to the prescribing information for all opioid analgesic medicines used in the outpatient setting to provide more information about how health care providers can safely decrease the dose in patients who are physically dependent on opioids, the agency announced Tuesday (April 9).

April 09, 2019 | Daily News

The House Ways & Means Committee on Tuesday (April 9) unanimously approved drug-pricing legislation that would demand price transparency from drug makers and pharmacy benefit managers.

April 09, 2019 | Daily News

Lawmakers in Maryland passed a scaled-back bill late Monday (April 8) that would create a board to review the affordability of prescription drugs, and potentially set ceilings for government payment of certain high-cost drugs.

April 08, 2019 | Daily News

CMS’ planned premium risk-reduction demonstration is designed to mask HHS’ bad drug-pricing policy, according to Sen. Ron Wyden (OR), the ranking Democrat on the Finance Committee.

April 08, 2019 | Daily News

American Hospital Association Executive Vice President Tom Nickels urged 340B hospitals on Monday (April 8) to join the group’s voluntary 340B reporting initiative -- which more than 900 hospitals have already done -- as he said hospitals face a choice between voluntary reporting or legislation and regulation.

April 08, 2019 | Daily News

Since his early March announcement that he would be leaving FDA, former agency commissioner Scott Gottlieb ramped up work to wrap up, or initiate, myriad goals he wanted to accomplish during his time with the agency.

April 08, 2019 | Daily News

Congressional Medicare advisers on Friday (April 5) mulled a proposal to fundamentally restructure the Medicare Part D coverage gap and catastrophic phase to prepare the system for an impending influx of high-cost specialty drugs.

April 05, 2019 | Daily News

CMS on Friday (April 5) finalized policies that will allow Medicare Advantage plans to cover more telehealth services as basic benefits and will streamline benefits and appeals for dually enrolled beneficiaries.

April 05, 2019 | Daily News

HHS’ proposed overhaul of drug rebates is expected to lead to higher Medicare Part D premiums, but CMS is helping insurers keep premiums artificially low by letting them choose to have taxpayers cover the cost of setting premiums too low for the first two years, sources say.

April 05, 2019 | Daily News

FDA will consider the extent to which a drug’s intended population is expected to use the product for off-label uses when deciding whether to require a risk mitigation program for certain drugs, a policy the brand industry had alleged may exceed the agency’s statutory authority.

April 05, 2019 | Daily News

After his tenure ends Friday, FDA Commissioner Scott Gottlieb will return to the conservative American Enterprise Institute, a group that has been a favorite resource on drug-pricing issues for Republicans.

April 05, 2019 | Daily News

FDA and Customs and Border Protection (CBP) signed an agreement Thursday (April 4) to expand how information is shared between the two agencies and coordinate shared space to target entry of illicit drugs coming into the country through international mail facilities (IMFs).

April 05, 2019 | Daily News

The overhaul of the Medicare and Medicaid drug rebate systems would be handled as a voluntary two-year pilot starting in 2020, according to CMS guidance.

April 05, 2019 | Daily News

The overhaul of the Medicare and Medicaid drug rebate systems would be accompanied by a voluntary two-year pilot starting in 2020, according to CMS guidance.

April 04, 2019 | Daily News

The House Ways & Means Committee is expected to hold a hearing next week on four bipartisan bills aimed at lowering prices after the House Energy & Commerce Committee this week passed six separate bipartisan bills aimed at speeding generic drug competition.

April 04, 2019 | Daily News

Senate health committee chair Lamar Alexander highlighted some suggestions for lowering prescription drug costs that he received from think tanks and stakeholders during a floor speech Thursday (April 4).

April 04, 2019 | Daily News

The White House budget staff are reviewing CMS’ final rule to lower Part D drug costs, which might include eliminating coverage protections in six drug classes, according to the Office of Management and Budget website.

April 04, 2019 | Daily News

Days before the end of his tenure at FDA, agency commissioner Scott Gottlieb laid out a roadmap for FDA to shape its regulatory system for drug compounding in 2019.

Pages